- Conditions
- Pediatric Patient (1m-21y), ICU Admission, Hyperglycemia
- Interventions
- Active Glycemic Control Strict (80-140mg/dL) vs. Conservative (190-220mg/dL) (with or without Continuous Glucose Monitoring)
- Other
- Lead sponsor
- Indiana University
- Other
- Eligibility
- 1 Month to 18 Years
- Enrollment
- 153 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2015
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1273–1296
of 8,511
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Diabetes Mellitus Type 2, Hypertension
- Interventions
- Produce Prescription, Nutrition Education
- Other · Behavioral
- Lead sponsor
- Tufts University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 610 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2027
- U.S. locations
- 3
- States / cities
- Bentonville, Arkansas • Des Moines, Iowa • Cincinnati, Ohio
- Conditions
- Type 1 Diabetes, Hypoglycemia Associated Autonomic Failure
- Interventions
- Fluoxetine, Placebo control
- Drug
- Lead sponsor
- University of Maryland, Baltimore
- Other
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 64 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2012 – 2025
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Weight Loss, Gestational Diabetes Mellitus in Pregnancy, Postpartum Care
- Interventions
- Metformin Hcl 850Mg Tab, Lifestyle Intervention, Enhanced Lifestyle Intervention
- Drug · Behavioral
- Lead sponsor
- George Washington University
- Other
- Eligibility
- 18 Years to 45 Years · Female only
- Enrollment
- 41 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Washington D.C., District of Columbia
- Conditions
- Chronic Kidney Disease, Hypertension, Diabetes
- Interventions
- Exercise training
- Behavioral
- Lead sponsor
- Springfield College
- Other
- Eligibility
- 35 Years to 70 Years
- Enrollment
- 51 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2012
- U.S. locations
- 1
- States / cities
- Springfield, Massachusetts
- Conditions
- Psoriasis, Metabolic Syndrome, Hyperlipidemia, Obesity, Hypertension
- Interventions
- Etanercept
- Drug
- Lead sponsor
- Massachusetts General Hospital
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 18 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2013
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Placebo, LY2922470
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 66 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 4
- States / cities
- Chula Vista, California • Eatontown, New Jersey • New York, New York + 1 more
- Conditions
- PreDiabetes
- Interventions
- Episodic Future Thinking, Episodic Recent Thinking, Scarcity Narrative, Neutral Narrative
- Behavioral
- Lead sponsor
- Leonard Epstein
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 78 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018
- U.S. locations
- 2
- States / cities
- Buffalo, New York • Roanoke, Virginia
- Conditions
- Diabetes
- Interventions
- Tailored Patient Intervention, Patient-physician intervention, Patient and PCP intervention with analyzed data
- Device
- Lead sponsor
- University of Maryland, Baltimore
- Other
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 213 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2011
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Gestational Diabetes
- Interventions
- Screening for diabetes with 1-hour GCT and HbA1
- Drug
- Lead sponsor
- University of Illinois Chicago
- Other
- Eligibility
- 18 Years to 49 Years · Female only
- Enrollment
- 600 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Obesity, Insulin Resistance
- Interventions
- hyperinsulinemic-euglycemic clamp
- Drug
- Lead sponsor
- University of Michigan
- Other
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 26 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016 – 2019
- U.S. locations
- 1
- States / cities
- Ann Arbor, Michigan
- Conditions
- Diabetes, Diabetes Mellitus, Type 2
- Interventions
- semaglutide, insulin glargine
- Drug
- Lead sponsor
- Novo Nordisk A/S
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,089 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 136
- States / cities
- Birmingham, Alabama • Ozark, Alabama • Tuscumbia, Alabama + 117 more
- Conditions
- Type 1 Diabetes, Children, Only
- Interventions
- telehealth visits
- Other
- Lead sponsor
- Georgetown University
- Other
- Eligibility
- 11 Years to 18 Years
- Enrollment
- 32 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2024
- U.S. locations
- 1
- States / cities
- Washington D.C., District of Columbia
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- 400 mg LX4211, 1000 mg metformin
- Drug
- Lead sponsor
- Lexicon Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 18 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- Started 2011
- U.S. locations
- 1
- States / cities
- San Antonio, Texas
- Conditions
- Hyperlipidemias, Overweight and Obesity, Diabetes
- Interventions
- TeleMOVE!, Culinary Rx
- Behavioral
- Lead sponsor
- Phoenix VA Health Care System
- Federal
- Eligibility
- 18 Years to 89 Years
- Enrollment
- 87 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2021
- U.S. locations
- 1
- States / cities
- Phoenix, Arizona
- Conditions
- Diabetes
- Interventions
- Zinc acetate
- Dietary Supplement
- Lead sponsor
- University of Maryland, Baltimore
- Other
- Eligibility
- 21 Years to 70 Years
- Enrollment
- 57 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2012
- U.S. locations
- 1
- States / cities
- Lancaster, Pennsylvania
- Conditions
- Angina, Unstable, Cardiovascular Diseases, Heart Diseases, Coronary Disease, Myocardial Infarction, Heart Failure, Congestive
- Interventions
- GIK, Placebo
- Drug
- Lead sponsor
- Tufts Medical Center
- Other
- Eligibility
- 30 Years and older
- Enrollment
- 911 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2012
- U.S. locations
- 13
- States / cities
- Anchorage, Alaska • New Haven, Connecticut • Macon, Georgia + 10 more
- Conditions
- Diabetes Type II
- Interventions
- Low Carbohydrate Diet, American Diabetes Association Diet, Mindfulness and Positive Affect Skills
- Behavioral
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 34 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2013
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Hypercholesterolemia, Mixed Dyslipidemia, Type 2 Diabetes
- Interventions
- Evolocumab, Placebo to Evolocumab
- Biological · Drug
- Lead sponsor
- Amgen
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 424 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 46
- States / cities
- Tuscumbia, Alabama • Phoenix, Arizona • Lomita, California + 39 more
- Conditions
- Diabetes, Hypoglycemia
- Interventions
- BHT-3021, BHT-Placebo
- Drug
- Lead sponsor
- Bayhill Therapeutics
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 80 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2011
- U.S. locations
- 10
- States / cities
- Birmingham, Alabama • Fresno, California • Aurora, Colorado + 7 more
- Conditions
- Hypertension
- Interventions
- olmesartan medoxomil, Olmesartan medoxomil plus Hydrochlorothiazide
- Drug
- Lead sponsor
- Daiichi Sankyo
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 192 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 27
- States / cities
- Birmingham, Alabama • Mesa, Arizona • Searcy, Arkansas + 24 more
- Conditions
- Type 2 Diabetes
- Interventions
- ISIS-GCGRRx- Dose Level 1, ISIS-GCGRRx- Dose Level 2, Placebo
- Drug
- Lead sponsor
- Ionis Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 79 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 19
- States / cities
- Greenbrae, California • Huntington Park, California • La Mesa, California + 14 more
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Dexcom CGM
- Device
- Lead sponsor
- Jaeb Center for Health Research
- Other
- Eligibility
- 60 Years and older
- Enrollment
- 200 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2019
- U.S. locations
- 22
- States / cities
- Beverly Hills, California • La Jolla, California • Aurora, Colorado + 17 more
- Conditions
- Type 2 Diabetes
- Interventions
- DIO-902, DIO-902 placebo
- Drug
- Lead sponsor
- DiObex
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 12
- States / cities
- Muscle Shoals, Alabama • Tucson, Arizona • Jonesboro, Arkansas + 9 more